Klearman Micki 4
4 · Kezar Life Sciences, Inc. · Filed Jun 21, 2024
Insider Transaction Report
Form 4
Klearman Micki
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-20+50,000→ 50,000 totalExercise: $0.67Exp: 2034-06-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]One-hundred percent (100%) of the shares subject to the option shall vest on 6/20/2025, subject to Reporting Person continuing to provide service through such date.